
340.78 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 231.87 Today|||52-Week Range 384.44 | -6.85% Year-to-Date |
A Look at Pharma ETFs Post Q4 Earnings 10:05am / Zacks.com - Paid Partner Content | AbbVie Q4 Preview: What's in Store? Feb 03 / Zacks.com - Paid Partner Content |
Aull & Monroe Investment Management Corp Buys 1, Sells 4 in 4th Quarter 9:00am / GuruFocus News - Paid Partner Content | Pharma Stock Roundup: MRK, LLY, PFE Q4 Results, J&J's Loss in Talc Lawsuits Feb 03 / Zacks.com - Paid Partner Content |
Is Eli Lilly Stock a Buy Now? 9:00am / MotleyFool.com - Paid Partner Content | Lilly (LLY) Reports Q4 Earnings: What Key Metrics Have to Say Feb 03 / Zacks.com - Paid Partner Content |
Top 5 4th Quarter Trades of Column Capital Advisors, LLC Feb 06 / GuruFocus News - Paid Partner Content | Eli Lilly (LLY) Q4 2022 Earnings Call Transcript Feb 02 / MotleyFool.com - Paid Partner Content |
1 Company Bucks the Office REIT Trend With Higher Rents and Earnings Feb 06 / MotleyFool.com - Paid Partner Content | Lilly (LLY) Beats on Q4 Earnings, Lags on Sales, Raises '23 View Feb 02 / Zacks.com - Paid Partner Content |
Previous close | 339.68 |
Today’s open | 337.57 |
Day’s range | 337.57 - 342.79 |
Volume | 2,289,109 |
Average volume (3 months) | 2,911,046 |
Market cap | $314.2B |
Earnings growth (last year) | -- |
Earnings growth (this year) | +6.74% |
Earnings growth (next 5 years) | +23.86% |
Revenue growth (last year) | +0.79% |
P/E ratio | 51.4 |
Price/Sales | 11.60 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
MRKMerck | +0.97 | +0.92% |
ABBVAbbVie | -0.55 | -0.38% |
PFEPfizer | +0.38 | +0.87% |
NVONovo Nordisk | 0.00 | 0.00% |
Next reporting date | April 27, 2023 |
EPS forecast (this quarter) | $1.72 |
Annual revenue (last year) | $28.5B |
Annual profit (last year) | $6.2B |
Net profit margin | 21.88% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |